Cunningham Hit Ground Running When It Came To Tamping Down on Drug Prices

December 4, 2019 by Dan McCue

WASHINGTON – In the Lowcountry of South Carolina, Rep. Joe Cunningham’s race for Congress quickly became the stuff of local legend.

Here was a first-time candidate, a Democrat running in a staunchly Republican district, who defeated a well-financed GOP opponent, to become the first Democratic representative from South Carolina’s 1st Congressional District since 1981.

But the ever-energetic congressman didn’t stop there. Almost as soon as he arrived in Washington, at a time when many newcomers were still losing their way in the Capitol’s winding hallways, he was looking to fulfill some important campaign promises.

The first was filing a bill to ban offshore oil and gas exploration off the South Carolina coast. Soon thereafter, he actively joined efforts in the House to lower the cost of prescription drugs.

“One of my earliest constituent meetings was with Lowcountry parents who struggle to afford life-saving insulin for their children,” Cunningham recently said of the urgency he felt.

“In the last five years, the cost of one of the most common brands of insulin has increased from $2,907 a year to more than $4,700 a year. Meetings like these reaffirm to me how urgent this issue is,” he said.

In May, he voted in favor of H.R. 986, a bipartisan bill designed to strengthen protections for people with pre-existing conditions, an effort to buttress the Affordable Care Act against administration efforts to weaken it.

He followed up that vote, by introducing the CLAY Act, which would lower the cost of prescription drugs for beneficiaries who receive the low-income subsidy (LIS) in Medicare Part D.

More recently, Cunningham joined with fellow members of the Blue Dog Coalition of moderate House Democrats to endorse a series of prescription drug pricing bills that they believe, if taken up individually, could pass a Democratic-led House and a Republican-led Senate.

They include the CREATES Act and BLOCKING Act, bills aimed at helping generic drug makers bring their products to market more quickly while also lifting barriers to competition.

Cunningham told The Well News that when it comes to the issue of drug pricing, he expects meaningful results to be achieved, even against the headwinds of the ongoing impeachment proceedings and the impending 2020 political campaigns.

“Of course I do,” he said.

“My top priority in Congress is to serve the people of the Lowcountry and I know that my colleagues on both sides of the aisle feel the same way about their districts and their constituents,” Cunningham said.

“Lowering the cost of prescription drugs isn’t a Democratic or Republican issue – it’s an American one,” he added.

“Frankly, this issue is far beyond politics, this is about quality of life,” he said. “Nearly 3-in-10 South Carolinians have reported that they’ve had to stop taking medication as prescribed because of cost in the last year,” he said. “We need to get this legislation signed into law as soon as possible for them – and for folks across the nation.”

Prescription Drugs

Merck Says Experimental Pill Cuts Worst Effects of COVID-19

WASHINGTON (AP) — Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people... Read More

WASHINGTON (AP) — Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared,... Read More

September 14, 2021
by Dan McCue
Moderates Seek Changes to Drug Pricing Proposal

A group of moderate Democrats led by Rep. Scott Peters sought on Tuesday to change the House debate on how... Read More

A group of moderate Democrats led by Rep. Scott Peters sought on Tuesday to change the House debate on how prescription drug prices are set in the U.S., arguing sweeping proposals put forward by progressives could threaten passage of the $3.5 trillion budget bill. The push... Read More

September 9, 2021
by Dan McCue
White House Unveils Plan to Cut Prescription-Drug Prices

WASHINGTON -- The Biden administration on Thursday offered the first detailed look at actions the White House may take in... Read More

WASHINGTON -- The Biden administration on Thursday offered the first detailed look at actions the White House may take in conjunction with congressional action to lower prescription drug prices. The 29-page plan, released through the Department of Health and Human Services, backs the intention of many... Read More

September 1, 2021
by Dan McCue
Kansas Health Officials Urging Residents Not to Take Livestock Drug for COVID

TOPEKA, Kan. - A drug most commonly given to horses and cows as an anti-parasite medicine should not be taken... Read More

TOPEKA, Kan. - A drug most commonly given to horses and cows as an anti-parasite medicine should not be taken by humans to treat or prevent COVID-19, the Kansas Department of Health and Environment said in a Wednesday advisory. Ivermectin was introduced as a veterinary drug... Read More

Judge Set to Rule on Purdue Pharma's Opioid Settlement Plan

A federal bankruptcy judge is expected to rule Wednesday on whether to accept a settlement between OxyContin maker Purdue Pharma,... Read More

A federal bankruptcy judge is expected to rule Wednesday on whether to accept a settlement between OxyContin maker Purdue Pharma, the states and thousands of local governments over an opioid crisis that has killed a half-million Americans over the last two decades. If Judge Robert Drain... Read More

August 23, 2021
by Dan McCue
Poll: NJ Voters Want a Fiscally Responsible Congress to Tackle True Health Care Concerns

Voters in New Jersey’s 5th Congressional District, a traditional swing or battleground district nestled against the southeast portion of New... Read More

Voters in New Jersey’s 5th Congressional District, a traditional swing or battleground district nestled against the southeast portion of New York State, are united in many key respects when it comes to spending and health care reforms, a recent survey found. Strong majorities want to see... Read More

News From The Well
Exit mobile version